Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05
Published November 23, 2022 · Recall initiated: October 21, 2022
Summary
FDA records drug Class II recall D-0063-2023, published November 23, 2022 and initiated October 21, 2022. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 2,794 bottles; Lot: Lot #: 3150116, Exp 2/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Viatris Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot #: 3150116, Exp 2/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDALevothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b)December 18, 2024
- FDALevothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b)December 18, 2024
- FDA0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest,November 23, 2022
- FDAPF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500November 23, 2022
Questions about this recall
Was Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05 recalled?
Yes. FDA published recall D-0063-2023 on November 23, 2022. Reported hazard: Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
What should I do if I have this product?
Voluntary: Firm initiated · Letter